teduglutide 0.05 mg/kg/d
CL0600-005
Phase 3 small_molecule completed
Quick answer
teduglutide 0.05 mg/kg/d for Short Bowel Syndrome is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Short Bowel Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed